Literature DB >> 31048103

Coronary computed tomography angiography and echocardiography in children with homozygous familial hypercholesterolemia.

Ilse K Luirink1, Irene M Kuipers2, Barbara A Hutten3, Robrecht N Planken4, Adrianus P C M Backx2, Jaap W Groothoff5, Albert Wiegman6.   

Abstract

BACKGROUND AND AIMS: Homozygous familial hypercholesterolemia (hoFH) is a rare genetic disease, hallmarked by a lifelong exposure to very high levels of low-density lipoprotein cholesterol (LDL-C). Untreated, patients can experience a cardiovascular event in the first decade of life. Early detection and monitoring of subclinical atherosclerosis in these patients is therefore extremely important. We set out to assess the diagnostic yield of low-dose coronary computed tomography angiography (cCTA) compared to echocardiography in detecting subclinical atherosclerosis.
METHODS: For this single-center cross-sectional study, we included all pediatric hoFH patients treated with lipoprotein-apheresis (LA) in Amsterdam UMC. We performed both cCTA and echocardiography in all patients as part of routine follow-up.
RESULTS: Six hoFH patients were included. Median ages at diagnosis, onset of LA and cardiovascular assessment (cCTA and echocardiography) were 2.6, 6.5, 10.8 and 11.1 years, respectively. Echocardiography revealed no signs of atherosclerosis in any of the six patients. In two patients, mild dilatation of the cardiac chambers was detected and two patients showed signs of mitral or aortic insufficiency. On cCTA, however, non-calcified plaques without stenosis were detected in four patients. In two patients calcified coronary plaques were found at the ostia of the right coronary artery or the left main coronary artery. Aortic root calcifications were found in two patients.
CONCLUSIONS: Our findings suggest that in hoFH children, low-dose cCTA is superior to echocardiography for the detection of subclinical coronary and aortic root atherosclerosis and should therefore be considered in the routine cardiovascular monitoring of these high-risk children.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Echocardiography; Familial hypercholesterolemia; Homozygous; Imaging; cCTA

Mesh:

Year:  2019        PMID: 31048103     DOI: 10.1016/j.atherosclerosis.2019.04.219

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  4 in total

Review 1.  Recent Advances on Familial Hypercholesterolemia in Children and Adolescents.

Authors:  Francesca Mainieri; Veronica Maria Tagi; Francesco Chiarelli
Journal:  Biomedicines       Date:  2022-04-30

Review 2.  Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care.

Authors:  Gerald F Watts; Samuel S Gidding; Pedro Mata; Jing Pang; David R Sullivan; Shizuya Yamashita; Frederick J Raal; Raul D Santos; Kausik K Ray
Journal:  Nat Rev Cardiol       Date:  2020-01-23       Impact factor: 32.419

3.  Case Report: Hypercholesterolemia "Lean Mass Hyper-Responder" Phenotype Presents in the Context of a Low Saturated Fat Carbohydrate-Restricted Diet.

Authors:  Nicholas G Norwitz; Adrian Soto-Mota; David Feldman; Stefanos Parpos; Matthew Budoff
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-14       Impact factor: 6.055

Review 4.  Homozygous Familial Hypercholesterolemia.

Authors:  Atsushi Nohara; Hayato Tada; Masatsune Ogura; Sachiko Okazaki; Koh Ono; Hitoshi Shimano; Hiroyuki Daida; Kazushige Dobashi; Toshio Hayashi; Mika Hori; Kota Matsuki; Tetsuo Minamino; Shinji Yokoyama; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-04-18       Impact factor: 4.928

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.